Altimmune to test obesity drug for alcohol use disorder and related health conditions
Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat alcohol use disorder and alcohol-associated liver disease. WHY IT'S IMPORTANT ...
Medscape26d
Benzyl Alcohol Allergy: Importance of Patch Testing with Personal Products
The result of patch testing with purified corticosteroids ... Although he had a positive patch-test reaction to benzyl alcohol 5%, no depigmentation was observed at the test site for 2 years.
InsideBitcoins10d
The Concerning Connection Between Alcohol Use and Sports Betting
Recent research has unveiled a significant correlation between alcohol consumption patterns and sports betting behaviors, ...
TechCrunch20d
US employee screening giant DISA says hackers accessed data of more than 3M people
DISA, which provides services like drug and alcohol testing and background ... which includes individuals who underwent employee screening tests, DISA said the attacker “procured some ...
Bleeping Computer20d
US drug testing firm DISA says data breach impacts 3.3 million people
DISA Global Solutions, a leading US background screening and drug and alcohol testing firm, has suffered a data breach impacting 3.3 million people. In January, the company first disclosed a ...
BioSpace3d
Altimmune To Test Investigational GLP-1–Based Obesity Drug for Alcohol Use Disorder
The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...